BMRNNasdaqPharmaceutical PreparationsFiscal year ends December 31
BIOMARIN PHARMACEUTICAL INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$54.67−0.01 (-0.02%)
Close on Oct 19, 2026
- Market cap
- $10.63B
- P/E (TTM)
- 143.9
- Dividend yield
- –
SEC filings
40 of Biomarin Pharmaceutical's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 6, 2026 | Oct 6, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2026 | Sep 30, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 15, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 10, 2026 | Sep 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 31, 2026 | Sep 1, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 30, 2026 | Aug 31, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 17, 2026 | Aug 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 6, 2026 | Aug 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 2, 2026 | Jun 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 5, 2026 | SEC EDGAR |
| Current report | 8-K | May 4, 2026 | May 4, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 27, 2026 | Apr 27, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 23, 2026 | Apr 23, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 2, 2026 | Apr 21, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Feb 26, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 12, 2026 | Feb 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2026 | Jan 29, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 26, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 22, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Oct 28, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 27, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2025 | Oct 7, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2025 | Aug 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 5, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 4, 2025 | Aug 4, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Aug 1, 2025 | SEC EDGAR |
| Current report | 8-K | May 20, 2025 | May 22, 2025 | SEC EDGAR |
| Current report | 8-K | May 16, 2025 | May 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 2, 2025 | SEC EDGAR |
| Current report | 8-K | May 1, 2025 | May 1, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | May 20, 2025 | Apr 8, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2025 | Mar 3, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 20, 2025 | Feb 24, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 24, 2025 | SEC EDGAR |